Indication
Mild Autonomous Cortisol Excess
1 clinical trial
1 product
Clinical trial
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal WomenStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Elagolix